Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 1 EP application Rachel Maria Lowry has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after June 29, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP14171857

Phenoxypyridinylamide derivatives and their use in the treatment of PDE4 mediated disease states

IPC classification:
A61K 31/455, C07D 498/04, C07D 487/04, C07D 471/04, C07D 417/14, C07D 417/12, C07D 413/14, C07D 413/12, C07D 401/14, C07D 401/12, C07D 213/82, A61P 37/00, A61P 35/00, A61P 25/00, A61P 9/00
Applicant:
Galderma S.A.
Applicant:
AstraZeneca AB
Agent:
AstraZeneca PLC
Agent:
Rachel Maria Lowry, AstraZeneca UK Limited
Status:
PATENT GRANTED

Please Sign in to use this feature